Advanced search
Publication Cover
Näringsforskning Volume 41, 1997 - Issue 1
Journal homepage
372
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Can dietary flavonoids influence the development of coronary heart disease?

Helle Margrete MeltzerNordic School of Nutrition, School of Medicine, Univ. of Oslo, P.O. Box 1046, Blindern, N-03 16Oslo, Norway.
, Ph.D. &
Karl Egil MalterudDept. of Pharmacognosy, Institute of Pharmacy, The Univ. of Oslo, PO Box 1068, Blindern, N-0316Oslo, Norway Email: [email protected]
(Prof.)
Pages 50-57 | Published online: 13 Dec 2016

  • Steinmetz KA, Potter JD: Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Contr 1991; 2: 325–57.
  • Steinmetz KA, Potter JD: Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Contr 1991; 2: 427–42.
  • Dragsted LO, Strube M, Larsen JC: Cancer-protective factors in fruits and vegetables: Biochemical and biological background, Pharmacol Toxicol 1993;72 (Suppl 1):116–35.
  • Willett WC:Diet and health: What should we eat? Science 1994; 264: 532–7.
  • Renaud S, de Lorgeril M: Wine, alcohol, plateletsand the French paradox for coronary heart disease. Lancet 1992; 339: 1523–6.
  • Kinsella JE, Frankel E, German B, Kanner J: Possible mechanisms for the protective role of antioxidants in wine and plant foods. Food Technol 1993; Apri1: 85-9.
  • Hertog MGL, Feskens E, JM, Hollmann PC, Katan MB, ICromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 1993; 342: 1007–11.
  • Hertog MGL: Les flavonoïdes dans le the, le yin rouge et les oigrions protegentils contre les maladies cardiovasculaires et le cancer? Poly-phenols Actualités 1995; 13: 17–9.
  • Wadworth SM, Lynch S: Dietary flavonoids in atherosclerosis prevention. Ann Pharmacother 1995;29;627–8.
  • Markham KR: Flavones, flavonols and their glycosides. In Harbome JB, ed. Methods in Plant Biochemistry, Vol. 1: Plant Phenolics. London: Academic Press, 1989: 197–235.
  • Herrmann K: Flavonols and flavones in food plants: a review. J Food Technol 1976; 32: 47–52.
  • Hemnann K: On the occurence of flavonol and flavone glycosides in vegetables. Z Lebensm Untersuch Forsch 1988; 186: 1–5.
  • Havsteen B: Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983; 32: 1141–8.
  • McClure 7: Physiology and functions of flavo-noids. In: Harbome JB, Mabry TJ, Mabry H, eds. The Flavonoids. London: Chapman & Hall, 1975: 970–1055.
  • Harbome JB. Grayer RI: Flavonoids and insects. In: Harborne JB, ed. The Flavonoids -Advances in Research since 1986. London: Chapman & Hall, 1994: 589-618.
  • Singleton VL: Flavonoids. Adv Food Res 1981; 27: 149–242.
  • Wang ZY, Das M, Bickers DR, Mulduar H: Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450. Drug Metab Disp 1988;16;98–103.
  • Ktilmau J: The flavonoids: a class of semi-essen-tial food components: their role in human nutri-tion. World Rev Nutr Diet 1976; 24: 117–91.
  • Hertog MGL, Hollman PCH, Venema DP: Optimization of a quantitative 1-1PLC deter-mination of potentially anticarcinogenic flavon-oids in vegetables and fruits 1 Agr Food Chem 1992; 40: 1591–8.
  • Hertog MGL, Hollman PCH, Katan MB: Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agr Food Chem 1992; 40: 2379-83.
  • Kandaswami C, Middleton E: Free radical sca-venging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 1994; 366: 351–76.
  • Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Rad Res 1995; 22: 373–83.
  • Cotelle N, Bemier J-L, Catteau JP, Pommery J, Wallet J-C, Gaydou W: Antioxidant properties of hydroxy-flavones. Free Rad Biol Med 1996; 20: 35–43.
  • Middleton E, Kandaswami C: Effects of flavo-noids on immune and inflammatory cell functions. Biochem Pharmacol 1992; 43: 1167–79.
  • Middleton E, Kandaswami C: The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer. In: Harbome JB, ed. The Flavonoids - Advances in Research since 1986. London: Chapman 8z Hall, 1994: 619-52.
  • Esterbauer H, Waeg G, Puhl H: Lipid peroxidation and its role in atherosclerosis, Br Med Bull 1993; 49: 566–76.
  • Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ltidin E: Increased risk of cardiovascular disease at suboptimal con-centrations of essential antioxidants: an epide-miological update with special attention to carotene and vitamin C. Am J Clin Nutr, Suppl 1993; 57: 787S-97S.
  • Bors W, Heller W, Michel C, Saran M: Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. Methods Enzymol 1990; 186: 343–55.
  • Malterud KE, Oanh DH, Sund RB. C-Methylated dihydrochalcones from Myrica gale L.: Effects as antioxidants and scavengers of 1,1-dipheny1-2-picrylhydrazyl. Pharmacol Toxicol 1996; 78: 111-6.
  • Mathiesen L, Malterud KE, Sund RB. Antioxidant activity of fruit exudate and C-methylated dihydrochalcones from Myrica gale L. Planta Med 1995; 61: 515–8.
  • Cotereau H, Gabe M, Géro E, Parrot J-L: In-fluence of vitamin P (vitamin C2) upon the amount of ascorbic acid in the organs of the guinea pig. Nature 1948; 161: 557–8.
  • Clemetson CAB, Andersen L: Plant polyphenols as antioxidants for ascorbic acid. Ann NY Acad Sci 1966; 136: 341–76.
  • Carave J-M, Hayaux du Tilly-Achard M, Parrot J-L: The C2 factor. In: Farkas L, Gabor M, Kallay F, eds. Flavonoids and bioflavonoids - Current research trends. Amsterdam: Elsevier, 1977: 439–43.
  • Bors W, Michel C, Schikora S: Interaction of flavonoids with ascorbate and determination of their univalent redox potentials: A pulse radiolysis study. Free Rad Biol Med 1995; 19: 45–52.
  • Steinberg D, Parthasarathy S, Carew T, Khoo JC, Witztum JL: Beyond cholesterol: Modifiers of low density lipoprotein that increase its atherogenicity. New Engl J Med 1989,315: 915–24.
  • Hoff HF, O'Neil JA: Oxidation of LDL: Role in atherogenesis. Klin Wochenschr 1991; 69: 1032–8.
  • Parthasarathy S, Rankin SM: Role of oxidized low density lipoprotein in atherogenesis. Progr Lipid Res 1992; 31: 127–43.
  • Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801–9.
  • Ray BR, Davisson BO, Crespi HL: Experiments on the degradation of lipoproteins from serum. J Phys Chem 1954; 58: 841–6.
  • Jessup W, Rankin SM, de Whalley C, Hoult JRS, Scott, J, Leake DS: a-Tocopherol consumption during low-density-lipoprotein oxidation. Bio-chem J 1990; 265: 399–405.
  • de Whalley CV, Rankin SM, Hoult JRS, Jessup W, Leake DS: Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 1990; 39: 1743–50.
  • Mangiapane H, Thomson J, Salter A, Brown S, Bell GD, White DA: The inhibition of the oxidation of low density lipoprotein by (+)-cate,chin, a naturally occurring flavonoid. Bio-chem Phannacol 1992; 43: 445–50.
  • Miura S, Watanabe J, Tomita T, Sano M, Tomita I: The inhibitory effects of tea polyphenols (flayan-3-ol derivatives) on Cu2+ mediated oxidative modification of low density lipoprotein. Biol Pharm Bull 1994; 17: 1567-72.
  • Miura S, Watanabe J, Sano M, Tomita T, Osawa T, Hara Y et al.: Effects of various natural antioxidants on the Cu2+-mediated oxidative modification of low density lipoprotein. Biol Pharm Bull 1995; 18: 1-4.
  • Manach C, Morand C, Texier O, Favier M-L, Agullo G, Demigné C et al.: Quercetin meta-bolites in plasma of rats fed diets containing rutin or quercetin. J Nutr 1995; 125: 1911-22.
  • Nègre-Salvayre A, Mabile L, Delchambre J, Salvayre R: a-Tocopherol, ascorbic acid, and rutin inhibit synergistically the copper-promoted LDL oxidation and the cytotoxicity of oxidized LDLto cultured endothelial cells. Biol Trace Elem Res 1995; 47: 81–91.
  • Mathiesen L, Malterud KE, Nenseter MS, Sund RB: Inhibition of low density lipoprotein oxidation by myrigalone B, a naturally occurring flavonoid. Phannacol Toxicol 1996; 78: 143–6.
  • Nègre-Salvayre A, Salvayre R: Quercetin pre-vents the cytotoxicity of oxidised low-density lipoproteins by macrophages. Free Rad Biol Med 1992; 12: 101–6.
  • Folic& VA, Nivar-Aristy RA, Krajewski LP, Cathcart MK: Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic lesions. J Clin Invest 1995; 96: 504–10.
  • Baumann J, Bruchhausen F, Wurm G: Flavonoids and related compounds as inhibitors of arachidonic acid peroxidation. Prostaglandins 1980; 20: 627–39.
  • Lyckander IM, Malterud KE: Lipophilic flavo-noids from Orthosiphon spicatus as inhibitors of 15-lipoxygenase. Acta Phann Nord 1992; 4: 159–66.
  • Frankel EN, Kanner J, German JB, Parks E, Kinsella JE: Inhibition of oxidation of human low-density lipoprotein by phenolic silbstances in red wine. Lancet 1993; 43: 454–7.
  • Fuhrman B, Lavy A, Aviram M: Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 1995; 61: 549–54.
  • Whitehead TP, Robinson D, Allaway S, Syms J, Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem 1995; 41: 32–5.
  • Naegeli T, Matis P: Die Bedeutung einiger Vitamine far die Behandlung der Thrombo-embolie. Int Z Vitaminforsch 1957; 27: 324–33.
  • Pulliero G, Moran S, Bettini V, Martino R, Mogno C, Lo Castro G: Ex vivo study of the inhibitory effects of Vacciniummyrtillus anthocyanosides on human platelet aggregation. Fitoterapia 1989; 60: 69–75.
  • Beretz A, Cazenave IF: Old and new natural products as the source of modem antithmmbotic drugs. Planta Med 1991;57 (suppl.): S68-72.
  • Sagesaka-Mitane Y, Miwa M, Okada S: Platelet aggregation inhibitors in hot water extract of green tea. Chem Phartn Bull 1990; 38: 790–3.
  • Chang W-C, Hsu F-L: Inhibition of platelet aggregation and arachidonate metabolism in platelets by procyanidins. Prostagl Leukotr Essent Fatty Acids 1989; 38: 181–8.
  • Kimura Y, Okuda T, Okuda H: Effects of flavo-noids from licorice roots (Glycyrrhiza infiata Bat.) on arachidonic acid metabolism and aggregation in human platelets. Phytother Res 1993; 7: 341-7.
  • McNicol A: The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase. Prostagl Leukotr Essent Fatty Acids 1993; 48: 379–84.
  • Morazzoni P, Magistretti MT Effects of Vaccinium myrtillus anthocyanosides on prostacyclin-like activity in rat arterial tissue. Fitoterapia 1986; 57: 11–4.
  • Moroney MA, Alcaraz MJ, Forder RA, Carey F, Houit IRS: Selectivity of neutrophil 5-lipoxy-genase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J Pharm Pharmacol 1988; 40: 787–92.
  • Laughton MJ, Evans PT Moroney MA, Hoult JRS, Halliwell B: Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives: Relationship to antioxidant activity and to iron-reducing ability. Biochem Pharmacol 1991; 42: 1673-81.
  • Gryglewski RJ, Korbut R, Robak J, Swies J: On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol 1987; 36: 317–21.
  • Guo S-C, Chen S-C, Chen L-H, Wu J-B, Wang J-P, Teng C-M: Potent antiplatelet, anti-inflam-matory and antiallergic isoflavanquinones fron the roots of Abrus precatorius. Planta Med 1995; 61: 307–12.
  • Menkin V: Anti-inflammatory activity of some water-soluble bioflavonoids. AmJ Physiol 1959; 196: 1205–10.
  • Busse WW, Kopp DE, Middleton E: Flavonoid modulation of human neutrophil function. J Allergy Clin Immunol 1984; 73: 801–9.
  • Tanno Y, Kakuta Y, Aikawa T, Shindoh Y, Ohno I, Takishima T. Effects of Qing-Fei-Tang (Seihai-to) and baicalein, its main component flavonoid, on lucigenin-dependent chemilumi-nescence and leukotriene B, synthesis of human alveolar macrophages. Am J Chin Med 1988; 16: 145–54.
  • van der Nat JM, van der Sluis WG, Thart LA, Van Dijk H, de Silva KTD, Labadie RP: Activity-guided isolation and identification of Azadirachta indica bark extract constituents which specifically inhibit chemiluminescence production by acti-vated human polymorphonuclear leukocytes, Planta Med 1991; 57: 65-8.
  • Limasset B, Le Doucen C, Dore J-C, Ojasoo T, Damon M, de Paulet AC: Effects of flavonoids on the release of reactive oxygen species by stimulating human neutrophils: multivariate analysis of structure-activity relationships. Biochem Pharmacol 1993; 46: 1257–71.
  • Wagner H: Search for new plant constituents with potential antiphlogistic and antiallergic activity. Planta Med 1989; 55: 235–41.
  • Cornèl M, Laszt L, eds.: Clinical pharmacology: Flavonoids and the vascular wall. Basel: Karger, 1972.
  • Voelter W, Jung G, eds.: 0-(3-Hydroxyethyl)-rutoside - experimentelle und ldinische Ergeb-nisse. Berlin: Springer, 1978.
  • Hahn G, Mayer A: Die Mariendistel. östen-Apoth-Ztg 1981; 35: 849–53.
  • Koch H: Leberschutz-Therapeutica (2. Teil). Pharm unserer Z 1980; 9: 65-74.
  • Conn HO, ed.: International workshop on (+)-cyanidano1-3 in diseases of the liver. London: Royal Society of Medicine/Academic Press, 1981.
  • Iwamoto M, Ishizaki T, Sato T: Klinische Wirlcung von Crataegute bei Herzerkrankungen ischäm-ischer und/oder hypertensiver Genese. Planta Med 1981; 42: 1–16.
  • De Smet PAGM: An introduction to herbal pharmacoepidemiology. J Ethnopharmacol 1993; 38: 197–208.
  • Hopfenmiiller W: Nachweis der therapeutischen Wirksamkeit eines Ginkgo biloba-Spezial-extralctes. Meta-Analyse von ll klinischen Stu-dien bei Patienten mit Himleistungsstörungen. Arzneim-Forsch 1994; 44: 1005-13.
  • Bibby MC, Double JA: Flavone acetic acid - from laboratory to clinic and back. Anti-Cancer Drugs 1993; 4: 3–17.
  • Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F et al.: Flavonoid intake in long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995; 155: 381–6.
  • Bentsäth A, Rusznyàlc S, Szent-Györgyi A: Vitamin nature of flavones. Nature 1936; 138:798.
  • Bentsath A, Rusznyak S, Szent-Györgyi A: Vitamin P. Nature 1937; 139: 326–7.
  • Harbome TB: Current trends in the chromato-graphic analysis of plant phenolics. In: Vlietinck AJ & Dommisse RA, eds. Advances in medicinal plant research. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1985: 135-51.
  • Ho M, Uyeda M, Iwanami T, Nakagawa Y: Flavo-noids as a possible preventive of dental caries. Agric Biol Chem 1984; 48: 2143–5.
  • Osawa K, Yasuda H, Maruyama T, Morita H, Takeya K, Itokawa H: Isoflavanones from the heartwood of Swartzia polyphylla and their antibacterial activity against cariogenic bacteria. Chem Pharm Bull 1992; 40: 2970–4.
  • Nakagawa M, Nakanishi K, Darko LL, Vick JA: Structures of cabenegrins A4 and A-II, potent anti-snake venoms. Tetrahedron Lett 1982; 23: 3855–8.
  • Shiseido Co. Ltd: Hair cosmetic, Japanese patent 62-153211, 1987.
  • Cody V, Middleton E, Harbome JB, eds.: Plant flavonoids in biology and medicine. Biochemical, pharmacological and structure-activity relationships. New York: Alan R. Liss, 1986.
  • Cody V, Middleton E, Harborne JB, Beretz A, eds.: Plant flavonoids in biology and medicine II. Biochemical, cellular and medicinal properties. New York: Alan R. Liss, 1988.
  • Da.s NP, ed.: Flavonoids in biology and medicine III: Current issues in flavonoids research. Singapore: National University of Singapore, 1990.
  • Pathak D, Pathak K, Singla AK: Flavonoids as medicinal agents - Recent advances, Fitoterapia 1991; 62: 371–89.
  • Wilson RH, Mortarotti TG, Doxtader EK: Toxicity studies on rutin. Proc Soc Exptl Biol Med 1947; 64: 324–7.
  • Ambrose AM, Robbins DJ, DeEds, F: Com-parative toxicities of quercetin and quercitrin. J Am Phann Ass Sci Ed 1952; 41: 119–22.
  • Lina BAR, Dreefvan der Meulen HC, Leegwater DC: Subchronic (13-week) oral toxicity of neohesperidin dihydrochalcone in rats, Food Chem Toxicol 1990; 28: 507-13.
  • Willhite CC: Teratogenic potenital of quercetin in the rat. Food Chem Toxicol 1982; 20: 75–9.
  • Daniel PT, Holzschuh J, Berg PA: The pathogenesis of cianidanol-induced fever. Eur J Clin Pharmacol 1988; 34: 241–7.
  • Jaeger A, Wain M, Neftel K: Side effects of flavonoids in medical practice. In: Cody V, Midd-leton E, Harbome TB, Beretz A, eds. Plant flavonoids in biology and medicine II. Bio-chemical, cellular and medicinal properties. New York: Alan R. Liss, 1988: 379-94.
  • Edwards JM, Raffauf RF, LeQuesne PW: Antineoplastic activity and cytotoxicity of fla-vones, isoflavones and flavanones. J Nat Prod 1979; 42: 85–91.
  • Boersma HI-I, Woerdenbag HJ, Bauer J, Scheithauer W, Kampinga HH, Konings AWT: Interaction between the cytostatic effects of quercetin and 5-fluorouracil in two human colorectal cancer cell lines. Phytomedicine 1994; 1: 239–44.
  • Wall ME: Antimutagenic agents from natural products. J Nat Prod 1992; 55: 1561–8.
  • Shamon LA, Pezzuto JM: Plant antimutagens: A review and strategy for the identification of therapeutically useful agents. In: Wagner H, Farnsworth NR, eds. Economic and medicinal plant research, volume 6, London: Academic Press, 1994: 235-97.
  • Pamukcu AM, Yalciner S, Hatcher J11, Bryan GT: Quercetin, a rat intestinal and bladder carcinogen in bracken fern (Pteridiurn aquilinum). Cancer Res 1980; 40: 3468–72.
  • Hertog MGL, Feskens EJM, Holman PCH, Katan MB, Kromhout D: Dietary flavonoids and cancer risk in the Zutphen elderly study. Nutr Cancer 1994; 22: 175–84.
  • Hertog MGL, Hollman PCH, van de Putte B: Content of potentially anticarcinogenic flavo-noids in tea infusions, wines and fruit juices. JAgr Food Chem 1993; 41: 1242–6.
  • Anthony MS, Clarkson TB, Hughes CL, Morgan TM, Burke GL: Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkey. J Nut 1996; 126: 43–50.
  • Bahorun T, Trotin F, Porrunery J. Vasseur J, Pinkas M: Antioxidant activities of Crataegus monogyna extracts. Planta Med 1994; 60: 323–8.
  • Schilssler M, Hölz1J, Frick U: Myocardial effects of flavonoids from Crataegus species. Arzneim-Forsch 1995; 45: 842–5.
  • Al Makdessi S, Sweidan H, Milliner S, Jacob R: Myocardial protection by pretreatment with Crataegus oxyacantha. An assessment by means of the release of lactate dehydrogenase by the ischemic and reperfused Langendorff heart. Arzneim-Forsch 1996; 46: 25–7.
  • Knekt P, Järvinen R, Reunanen A, Maatela J: Flavonoid intake and coronary mortality in Finland: a cohort study. Brit Med J 1996; 312: 478–81.
  • Keli SO, Hertog MGL, Feskens EJM, Kromhout D: Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch Intern Med 1996; 156: 637–42.
  • Merfort I, Heilmann J, Weiss M, Pietta P, Gardana C: Radical scavenger activity of three flavonoid metabolites studied by inhibition of chemi-luminescence in human PMNs. Planta Med 1996; 62: 289–92.
  • Kawabe M, Tomano S, Shibata M-A, Hirose M, Fukushima S, Ito N: Subchronic toxicity study of methyl hesperidin in mice. Toxicol Lett 1993; 69: 37–44.
  • Schmalle HW, Jarchow OH, Hausen BM, Schulz K-H: Aspects of the relationships between chemical structure and sensitizing potency of flavonoids and related compounds. In: Cody V, Middleton E, Harbome TB, eds. Plant flavonoids in biology and medicine. Biochemical, pharma-cological and structure-activity relationships. New York: Alan R Liss, 1986: 387–90.
  • Hausen BM, Bruhn G, Koenig WA: New hydroxyisoflavans as contact sensitizers in cocus wood Brya ebenus DC (Fabaceae). Contact Dermatitits 1991; 25: 149–55.
  • Hansen BM, Wollenweber E, Senff H, Post B: Propolis allergy (I). Origin, properties, usage and literature review. Contact Dermatitis 1987; 17: 163–70.
  • Hansen BM, Wollenweber E, Scoff H, Post B. Propolis allergy (II): The sensitizing properties of 1,1-dimethylallylic caffeic acid ester. Contact Dermatitis 1987; 17: 171–7.
  • Hausen BM, Evers P. Stiiwe H-T, König WA, Wollenweber E: Propolis allergy (IV). Studies with further sensitizers from propolis and constituents common to propolis, poplar buds and balsam of Peru. Contact Dermatitis 1992; 26: 36–44.
  • Whitten PL, Lewis C, Russell E, Naftolin F: Potential adverse effects of phytoestrogens. J Nutr 1995; 125: 771S-6S.
  • Bames S: Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995; 125: 777S-83S.
  • Herman C, Acllercreutz H, Goldin BR, Gorbach SL, Höckerstedt KAV, Watanabe S. et al.: Soybean phytoestrogen intake and cancer risk. J Nutr 1995; 125: 757S-70S.
  • Dunnick J, Halley JR: Toxicity and carcino-genicity studies of quercetin, a natural component of foods. Fundam Appl Toxicol 1992; 19: 423–31.
  • Ito N: Is quercetin carcinogenic? Jpn J Cancer Res 1992; 83: 312–4.
  • Stavric B: Quercetin in our diet: From potent mutagen to probable anticarcinogen. Clin Bio-chem 1994; 27: 245–8.
  • Das A, Wang JH, Lien ET Carcinogenicity, muta-genicity and cancer preventing activities of flavo-noids: A structure-system-activity relationship (SSAR) analysis. Progr Drug Res 1994; 42: 133–66.
  • Hollman PCH, vdgaag M, Mengelers MJB, van Trijp JMP, de Vries JHM, Katan MB: Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Rad Biol Med 1996; 21: 703–7.
  • Paganga G, Rice-Evans CA: The identification of flavonoids as glycosides in human plasma. FEBS Lett 1997; 401: 78–82.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.